Janus Henderson Group’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-19,777
Closed -$149K 2546
2024
Q1
$149K Buy
19,777
+2
+0% +$18 ﹤0.01% 2470
2023
Q4
$183K Sell
19,775
-37
-0.2% -$302 ﹤0.01% 2457
2023
Q3
$201K Buy
19,812
+4
+0% +$48 ﹤0.01% 2385
2023
Q2
$248K Sell
19,808
-25
-0.1% -$298 ﹤0.01% 2353
2023
Q1
$231K Buy
+19,833
New +$253K ﹤0.01% 2422
2022
Q4
Sell
-1,109,219
Closed -$10.8M 2473
2022
Q3
$10.8M Sell
1,109,219
-117,022
-10% -$1.55M 0.01% 657
2022
Q2
$17.8M Sell
1,226,241
-71,626
-6% -$1.22M 0.01% 586
2022
Q1
$33.9M Sell
1,297,867
-80,512
-6% -$2.28M 0.02% 612
2021
Q4
$54.6M Sell
1,378,379
-20,428
-1% -$931K 0.02% 515
2021
Q3
$70M Sell
1,398,807
-5,562
-0.4% -$303K 0.03% 458
2021
Q2
$78M Sell
1,404,369
-43,463
-3% -$2.32M 0.03% 442
2021
Q1
$67.7M Buy
1,447,832
+10,138
+0.7% +$491K 0.03% 465
2020
Q4
$62.6M Buy
1,437,694
+186,266
+15% +$6.87M 0.03% 485
2020
Q3
$45.8M Buy
1,251,428
+15,442
+1% +$524K 0.02% 519
2020
Q2
$36.1M Buy
1,235,986
+57,282
+5% +$1.58M 0.02% 569
2020
Q1
$30.8M Buy
1,178,704
+1,035,031
+720% +$31.6M 0.02% 571
2019
Q4
$4.99M Buy
143,673
+5,640
+4% +$187K ﹤0.01% 1056
2019
Q3
$4.37M Buy
+138,033
New +$5.43M ﹤0.01% 1074

Other funds holding HCAT

Janus Henderson Group's HCAT Position: Q2 2024 in Review

Janus Henderson Group sold out of Health Catalyst (HCAT) in Q2 2024, closing a stake of 19,777 shares — an estimated $149K sold.

Janus Henderson Group first reported a position in HCAT in Q3 2019 and held it in 18 quarters. The position peaked at $78M in Q2 2021. 161 funds tracked by Wall St. Rank hold HCAT as of Q2 2024.

  • Janus Henderson Group reported no remaining Health Catalyst position as of Q2 2024 after selling out during the quarter.
  • Janus Henderson Group sold 19,777 Health Catalyst shares in Q2 2024, an estimated $149K.
  • Janus Henderson Group first reported a position in Health Catalyst in Q3 2019 and held it in 18 quarters.
  • Janus Henderson Group's Health Catalyst position peaked at $78M in Q2 2021.
  • 161 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2024.

Based on Janus Henderson Group's 13F filing for Q2 2024, filed 14 Aug 2024.